Evaluation of interleukin-6 and its soluble receptor components sIL-6R and sgp130 as markers of inflammation in inflammatory bowel diseases

PURPOSE: Interleukin-6 (IL-6) production and signalling are increased in the inflamed mucosa in inflammatory bowel diseases (IBD). As published serum levels of IL-6 and its soluble receptors sIL-6R and sgp130 in IBD are from small cohorts and partly contradictory, we systematically evaluated IL-6, s...

Descripción completa

Detalles Bibliográficos
Autores principales: Nikolaus, Susanna, Waetzig, Georg H., Butzin, Sven, Ziolkiewicz, Monika, Al-Massad, Natalie, Thieme, Florian, Lövgren, Ulf, Rasmussen, Birgitte B., Reinheimer, Torsten M., Seegert, Dirk, Rosenstiel, Philip, Szymczak, Silke, Schreiber, Stefan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2018
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6002455/
https://www.ncbi.nlm.nih.gov/pubmed/29748708
http://dx.doi.org/10.1007/s00384-018-3069-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6002455/
https://www.ncbi.nlm.nih.gov/pubmed/29748708
http://dx.doi.org/10.1007/s00384-018-3069-8

Ejemplares similares